Abstract
s S75 DT and BTT. Mental scores were statistically improved for BTT patients at 3 and 6 months; DT patients showed numeric improvements but the differences did not achieve significance at any time point. Conclusion: CF-LVAD therapy results in significant improvement of QOL as assessed by serial SF-36. Compared with pre-implant, the physical improvements are sustained and statistically significant to 12 months in DT and BTT populations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
